Caroline Clairmont
Impact in
- Biotechnology top 0.5%
- Cancer Research and Treatments
- Genetics top 5%
- Virus-based gene therapy research
Papers in
-
- DNA Repair Mechanisms 5
- Glycosylation and Glycoproteins Research 2
-
- Cancer Research and Treatments 5
- Co-authors
- Mario Sznol (7 shared papers)C B Hirschberg (3 shared papers)Joann B. Sweasy (5 shared papers)Antonio De Maio (1 shared paper)Ann Cahill (2 shared papers)Robert Cavagnolo (1 shared paper)John Nemunaitis (1 shared paper)Craig E. Litz (1 shared paper)
- Journals
- Proceedings of the National Academy of Sciences (3 papers)Journal of Biological Chemistry (2 papers)Journal of Bacteriology (2 papers)Journal of Clinical Oncology (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesPolandSweden
In The Last Decade
Caroline Clairmont
19 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 82
- Biotechnology 516
- Genetics 315
- Oncology 235
- Molecular Biology 555
- Biomedical Engineering 340
Countries citing papers authored by Caroline Clairmont
This map shows the geographic impact of Caroline Clairmont's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caroline Clairmont with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caroline Clairmont more than expected).
Fields of papers citing papers by Caroline Clairmont
This network shows the impact of papers produced by Caroline Clairmont. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caroline Clairmont. The network helps show where Caroline Clairmont may publish in the future.
Co-authors
The 25 scholars most cited alongside Caroline Clairmont, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 291 | |
| 2 | 2003 | 266 | |
| 3 | 2004 | 119 | |
| 4 | 1992 | 119 | |
| 5 | Phase I and pharmacokinetic study of triapine, a potent ribonucleotide reductase inhibitor, administered daily for five days in patients with advanced solid tumors. | 2003 | 97 |
| 6 | 1997 | 83 | |
| 7 | 2004 | 78 | |
| 8 | 1997 | 47 | |
| 9 | 1992 | 39 | |
| 10 | 2004 | 37 | |
| 11 | 1999 | 36 | |
| 12 | 1996 | 26 | |
| 13 | 2000 | 20 | |
| 14 | 2005 | 15 | |
| 15 | 1998 | 13 | |
| 16 | 1990 | 9 | |
| 17 | 1993 | 7 | |
| 18 | 2000 | 4 | |
| 19 | Combination of KS119W with other antitumor agents for the treatment of murine and human tumor xenografts in mice | 2005 | 1 |
About Caroline Clairmont
Caroline Clairmont is a scholar working on Molecular Biology, Biotechnology, Genetics, Cancer Research and Pathology and Forensic Medicine, having authored 19 papers that have together received 1.3k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (5 papers), Cancer Research and Treatments (5 papers), Glycosylation and Glycoproteins Research (2 papers), Carcinogens and Genotoxicity Assessment (2 papers), Salmonella and Campylobacter epidemiology (2 papers), Genetic factors in colorectal cancer (2 papers), Virus-based gene therapy research (2 papers) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Biotechnology (516 citations), Genetics (315 citations), Oncology (235 citations), Molecular Biology (555 citations) and Biomedical Engineering (340 citations). Caroline Clairmont has collaborated with scholars based in United States, Poland and Sweden. Frequent co-authors include Mario Sznol, C B Hirschberg, Joann B. Sweasy, Antonio De Maio, Ann Cahill, Robert Cavagnolo, John Nemunaitis, Craig E. Litz, Casey Cunningham and Neil Senzer. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry, Journal of Bacteriology, Journal of Clinical Oncology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.